Sequencing two Tyr::CreERT2 transgenic mouse lines

Zackie Aktary1,2,3, Andre Corvelo4, Camille Estrin1,2,3

  • 1Institut Curie, INSERM U1021, Normal and Pathological Development of Melanocytes, PSL Research University, Orsay, France.

Insights

Researchers identified the integration sites of two Tyr::CreERT2 mouse models using whole genome sequencing. This information enables precise genotyping for studying melanocyte transformation.

Area of Science:

  • Genetics and Genomics
  • Developmental Biology
  • Cancer Biology

Background:

  • The Cre/loxP system enables targeted gene manipulation in biological research.
  • The Tyr::CreERT2 mouse model allows tamoxifen-inducible Cre recombinase activity in melanocytes.
  • Studying melanocyte transformation often utilizes transgenic models for genetic control.

Purpose of the Study:

  • To identify the genomic integration sites of two independent Tyr::CreERT2 transgenic mouse models.
  • To develop accurate PCR-based genotyping methods for these models.
  • To compare the advantages of the characterized Tyr::CreERT2 mouse models.

Main Methods:

  • Whole genome sequencing (WGS) of genomic DNA from Tyr::CreERT2 mouse models.
  • Bioinformatic analysis to pinpoint transgene integration sites within the C57BL/6 genome.
  • Design and validation of PCR primers for efficient and accurate genotyping.

Main Results:

  • The specific integration sites for both Tyr::CreERT2 transgenes were successfully identified.
  • Validated PCR primers provide a reliable method for distinguishing transgenic mice.
  • Characterization facilitates informed selection between the two available mouse models.

Conclusions:

  • Precise knowledge of transgene integration sites is crucial for characterizing transgenic models.
  • The developed genotyping strategy enhances the utility of Tyr::CreERT2 mice for melanocyte research.
  • This study provides valuable resources for researchers investigating melanocyte development and transformation.